The aim of this study is to analyze the prevalence and frequency of somatic mutations in well-known cancer susceptibility genes, BRCA1 and BRCA2 in a small cohort of malignant mesothelioma patients and explore its putative impact on protein properties contributing to cancer pathogenicity. This evidence concerns the gene BRCA2 and cancer.